Animal Intestinal Health Market Report, Global Industry Analysis, Market Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2023 - 2030

  • Published Date: Jan, 2024
  • Report ID: CR0185632
  • Format: Electronic (PDF)
  • Number of Pages: 212
  • Author(s): Joshi, Madhavi

Report Overview

The Animal Intestinal Health Market size was estimated at USD 6.5 billion in 2023 and is projected to reach USD 10 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2024-2030).

Animal Intestinal Health Market

(Market Size)
$6.5 billion
$10 billion
2023
2030
Source: Citius Research
Study Period 2018 - 2030
Base Year For Estimation 2023
Forecast Data Period 2024 - 2030
CAGR (2024-2030) 6.80%
2023 Market Size USD 6.5 billion
2030 Market Size USD 10 billion
Key Players DSM, BASF, ADM, Evonik, Nutreco

Market Summary

The Animal Intestinal Health Market is a critical segment within the global agriculture industry, focusing on enhancing the gastrointestinal well-being of livestock and poultry through various feed additives and supplements. This market addresses the increasing demand for sustainable animal protein production by improving nutrient absorption, boosting immunity, and reducing the incidence of diseases. Key products include probiotics, prebiotics, essential oils, and organic acids, which are integral to modern animal husbandry practices. The shift towards antibiotic-free farming has further accelerated the adoption of these solutions, as producers seek effective alternatives to maintain animal health and productivity. Geographically, the market is well-established in regions with intensive livestock farming operations, with significant contributions from both developed and emerging economies. Leading companies are investing in research and development to introduce innovative products that cater to the evolving needs of the industry. The market is characterized by a high degree of competition, with players striving to expand their product portfolios and geographic reach. Regulatory frameworks and consumer preferences for safe and quality animal products continue to shape market dynamics, driving the emphasis on natural and sustainable intestinal health solutions.

Key Highlights

The Animal Intestinal Health Market is distinguished by several key highlights that underscore its importance and growth trajectory. One significant aspect is the increasing adoption of antibiotic alternatives, driven by regulatory bans and consumer demand for residue-free meat products. This has led to a surge in the use of probiotics and prebiotics, which promote beneficial gut microbiota and enhance overall animal health. Another highlight is the integration of advanced technologies, such as microbiome sequencing and precision nutrition, enabling tailored solutions for different animal species and production systems. The market also benefits from the rising awareness among farmers about the economic advantages of improved intestinal health, including better feed conversion ratios, reduced mortality rates, and enhanced growth performance. Strategic collaborations and acquisitions among key players, such as Cargill, DSM, and ADM, are fostering innovation and market expansion. Additionally, the growing focus on animal welfare and sustainable farming practices is propelling the demand for natural and organic intestinal health products. These factors collectively contribute to the market's robustness and future potential, making it a pivotal area within the agriculture sector.

Drivers, Opportunities & Restraints

The Animal Intestinal Health Market is propelled by several drivers, including the global push towards antibiotic reduction in animal feed, which mandates the use of alternative health solutions to prevent diseases and promote growth. Increasing meat consumption and the need for efficient animal production systems further drive the demand for intestinal health products, as they ensure optimal nutrient utilization and overall herd health. Opportunities abound in the development of novel formulations, such as synbiotics and phytogenics, which offer enhanced efficacy and cater to the trend of natural farming. Expansion in emerging markets, particularly in Asia-Pacific and Latin America, presents significant growth potential due to rising livestock populations and increasing awareness about animal health management. However, the market faces restraints such as high costs associated with advanced intestinal health products, which can be a barrier for small-scale farmers. Regulatory hurdles and varying approval processes across regions also pose challenges, delaying product launches and market penetration. Additionally, lack of awareness and technical knowledge in underdeveloped areas may limit adoption. Despite these restraints, ongoing research and educational initiatives are expected to mitigate these issues over time.

Concentration Insights

The Animal Intestinal Health Market exhibits a concentrated landscape with a few major players dominating the global scene. Companies like Cargill, Incorporated, Royal DSM, Archer Daniels Midland Company, and Kemin Industries hold significant market shares due to their extensive product portfolios, strong research capabilities, and widespread distribution networks. These industry leaders focus on strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their market position and expand their geographic presence. For instance, acquisitions of specialized firms allow them to integrate innovative technologies and enhance their offerings in probiotics, prebiotics, and other gut health solutions. The market also features several mid-sized and regional players who cater to niche segments or specific geographical areas, contributing to a competitive yet consolidated environment. High barriers to entry, including stringent regulatory requirements and substantial R&D investments, further reinforce the concentration among established players. However, increasing demand for customized solutions and the rise of local manufacturers in emerging economies are gradually fostering a more diverse competitive landscape, prompting global giants to adapt and innovate continuously.

Type Insights

The Animal Intestinal Health Market is segmented by type into various product categories, each playing a distinct role in promoting gastrointestinal health. Probiotics, comprising beneficial bacteria like Lactobacillus and Bifidobacterium, are widely used to balance gut microbiota and enhance immune responses in animals. Prebiotics, such as fructooligosaccharides and mannan-oligosaccharides, serve as food for beneficial gut bacteria, supporting their growth and activity. Phytogenics, derived from plants and herbs, offer natural antimicrobial and anti-inflammatory properties, improving digestion and overall health. Organic acids, including formic acid and lactic acid, help in reducing pathogenic bacteria and lowering gut pH, thereby optimizing nutrient absorption. Essential oils are gaining traction for their antioxidant and antimicrobial benefits, contributing to improved intestinal integrity and animal performance. Each product type caters to specific needs across different animal species, including poultry, swine, ruminants, and aquaculture. The choice of product often depends on factors such as animal age, health status, and production goals, with combinations of these types frequently used for synergistic effects. Ongoing research continues to refine these products, enhancing their efficacy and applicability in diverse farming systems.

Application Insights

The application of animal intestinal health products spans across various livestock and poultry sectors, each with unique requirements and benefits. In the poultry industry, these products are crucial for preventing diseases like necrotic enteritis and improving feed efficiency, leading to higher meat and egg production. Swine applications focus on enhancing gut health to reduce weaning stress, minimize diarrhea incidence, and promote optimal growth rates. Ruminants benefit from intestinal health solutions through improved rumen function, better fiber digestion, and reduced risk of metabolic disorders, ultimately increasing milk yield and meat quality. Aquaculture represents a growing application area, where probiotics and prebiotics help maintain water quality and support fish health by bolstering immunity against pathogens. Additionally, companion animals are increasingly receiving intestinal health products to address issues like obesity and digestive disorders, reflecting the expanding scope of the market. The adoption varies based on production systems, with intensive farming operations relying heavily on these additives to maintain high productivity and animal welfare standards. Customized formulations are developed to meet the specific needs of each application, ensuring targeted and effective outcomes.

Regional Insights

The Animal Intestinal Health Market demonstrates varied dynamics across different regions, influenced by factors such as farming practices, regulatory policies, and economic conditions. North America holds a significant share, driven by high awareness about antibiotic-free production and advanced livestock farming techniques. The United States and Canada are key contributors, with strong demand for probiotics and prebiotics in poultry and swine sectors. Europe follows closely, characterized by stringent regulations on antibiotic use and a well-established organic farming movement. Countries like Germany, France, and the Netherlands are at the forefront, adopting innovative intestinal health solutions to meet consumer preferences for sustainable meat products. The Asia-Pacific region is experiencing rapid growth due to expanding livestock populations, rising meat consumption, and increasing investments in animal health. China, India, and Vietnam are emerging as lucrative markets, with growing adoption of feed additives to enhance productivity. Latin America and the Middle East & Africa are also witnessing steady growth, supported by modernization of farming practices and government initiatives to improve animal health. Each region presents unique opportunities and challenges, shaping the strategic approaches of market players.

Company Insights

Prominent companies in the Animal Intestinal Health Market include Cargill, Incorporated, which offers a wide range of products like probiotics and organic acids under its Nutrena and Provimi brands. Royal DSM is another key player, known for its innovative solutions in animal nutrition, including prebiotics and eubiotics through its acquisition of Novozymes' animal health business. Archer Daniels Midland Company provides comprehensive intestinal health products, leveraging its global presence and expertise in feed ingredients. Kemin Industries specializes in pathogen control and gut health optimization using essential oils and microbial blends. Chr. Hansen Holding A/S focuses on probiotic strains tailored for different animal species, emphasizing research-driven approaches. Other significant players include Lallemand Inc., with its yeast-based products, and Novus International, Inc., offering methionine and organic acid blends. These companies invest heavily in R&D to develop cutting-edge solutions and maintain competitive edges. Strategic partnerships, such as collaborations with research institutions and acquisitions of niche firms, are common tactics to enhance product offerings and expand market reach. Their efforts are geared towards addressing the evolving needs of the agriculture industry, ensuring sustainable and efficient animal production worldwide.

Recent Developments

Recent developments in the Animal Intestinal Health Market highlight a trend towards innovation and strategic expansion. Major players have launched new products, such as advanced probiotic formulations and combination products that offer synergistic benefits for gut health. For instance, companies are introducing multi-strain probiotics and encapsulated organic acids to enhance stability and efficacy in animal feed. Acquisitions and partnerships have been prominent, with firms like Royal DSM and Cargill acquiring smaller specialized companies to bolster their portfolios and technological capabilities. Research collaborations with academic institutions are accelerating the development of novel solutions, such as microbiome modulators and precision nutrition tools. Regulatory approvals for new ingredients and products in key regions like Europe and North America have facilitated market entry and growth. Additionally, there is a growing emphasis on sustainability, with companies investing in eco-friendly production processes and promoting products that reduce environmental impact. These developments reflect the market's dynamic nature and the continuous effort to meet the demands of modern agriculture for healthier, more productive livestock through innovative intestinal health solutions.

Report Segmentation

The report on the Animal Intestinal Health Market is segmented to provide a comprehensive analysis of various aspects. The segmentation by type includes probiotics, prebiotics, phytogenics, organic acids, and essential oils, each analyzed for their market impact and adoption rates. Application segmentation covers poultry, swine, ruminants, aquaculture, and companion animals, detailing the specific needs and benefits in each sector. Geographically, the market is divided into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with country-level insights for major economies. The report also segments based on form, such as dry and liquid products, and distribution channels, including direct sales and distributors. This detailed segmentation enables stakeholders to identify growth opportunities, understand regional dynamics, and make informed decisions. It highlights trends, challenges, and forecasts for each segment, providing a holistic view of the market landscape. The analysis is supported by data on key players, their strategies, and market shares within each segment, offering valuable insights for investors, manufacturers, and other industry participants.

FAQs

What is the role of probiotics in animal intestinal health? Probiotics introduce beneficial bacteria into the animal gut, helping to balance microbiota, enhance digestion, boost immunity, and prevent pathogenic infections, thereby improving overall health and productivity.

How do prebiotics differ from probiotics? Prebiotics are non-digestible fibers that stimulate the growth and activity of beneficial gut bacteria, whereas probiotics are live microorganisms that directly add to the microbial population in the intestine.

Why is the animal intestinal health market growing? The market is growing due to increasing demand for antibiotic-free animal production, rising meat consumption, and the need for efficient farming practices that ensure animal wellness and sustainable protein supply.

Which regions lead in the animal intestinal health market? North America and Europe are leading regions, driven by strict regulations on antibiotic use and high awareness, while Asia-Pacific is rapidly growing due to expanding livestock industries and increasing health concerns.

What are the key challenges in this market? Key challenges include high costs of advanced products, regulatory variations across regions, and limited awareness among farmers in developing areas, which can hinder widespread adoption.

Citius Research has developed a research report titled “Animal Intestinal Health Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” delivering key insights regarding business intelligence and providing concrete business strategies to clients in the form of a detailed syndicated report. The report details out the factors such as business environment, industry trend, growth opportunities, competition, pricing, global and regional market analysis, and other market related factors.

Details included in the report for the years 2024 through 2030

• Animal Intestinal Health Market Potential
• Segment-wise breakup
• Compounded annual growth rate (CAGR) for the next 6 years
• Key customers and their preferences
• Market share of major players and their competitive strength
• Existing competition in the market
• Price trend analysis
• Key trend analysis
• Market entry strategies
• Market opportunity insights

The report focuses on the drivers, restraints, opportunities, and challenges in the market based on various factors geographically. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The Animal Intestinal Health Market report is segmented on the basis of various market segments and their analysis, both in terms of value and volume, for each region for the period under consideration.

Animal Intestinal Health Market Segmentation

Market Segmentation

Regions Covered

• North America
• Latin America
• Europe
• MENA
• Asia Pacific
• Sub-Saharan Africa and
• Australasia

Animal Intestinal Health Market Analysis

The report covers below mentioned analysis, but is not limited to:

• Overview of Animal Intestinal Health Market
• Research Methodology
• Executive Summary
• Market Dynamics of Animal Intestinal Health Market
  • Driving Factors
  • Restraints
  • Opportunities
• Global Market Status and Forecast by Segment A
• Global Market Status and Forecast by Segment B
• Global Market Status and Forecast by Segment C
• Global Market Status and Forecast by Regions
• Upstream and Downstream Market Analysis of Animal Intestinal Health Market
• Cost and Gross Margin Analysis of Animal Intestinal Health Market
• Animal Intestinal Health Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030
  • Competition Landscape
  • Market Share of Major Players
• Key Recommendations

The “Animal Intestinal Health Market Report - Global Industry Analysis, Size, Share, Growth Trends, Regional Outlook, Competitive Strategies and Segment Forecasts 2024 - 2030” report helps the clients to take business decisions and to understand strategies of major players in the industry. The report delivers the market driven results supported by a mix of primary and secondary research. The report provides the results triangulated through authentic sources and upon conducting thorough primary interviews with the industry experts. The report includes the results on the areas where the client can focus and create point of parity and develop a competitive edge, based on real-time data results.

Animal Intestinal Health Market Key Stakeholders

Below are the key stakeholders for the Animal Intestinal Health Market:

• Manufacturers
• Distributors/Traders/Wholesalers
• Material/Component Manufacturers
• Industry Associations
• Downstream vendors

Animal Intestinal Health Market Report Scope

Report AttributeDetails
Base year2023
Historical data2018 – 2023
Forecast2024 - 2030
CAGR2024 - 2030
Quantitative UnitsValue (USD Million)
Report coverageRevenue Forecast, Competitive Landscape, Growth Factors, Trends and Strategies. Customized report options available on request
Segments coveredProduct type, technology, application, geography
Regions coveredNorth America, Latin America, Europe, MENA, Asia Pacific, Sub-Saharan Africa and Australasia
Countries coveredUS, UK, China, Japan, Germany, India, France, Brazil, Italy, Canada, Russia, South Korea, Australia, Spain, Mexico and others
Customization scopeAvailable on request
PricingVarious purchase options available as per your research needs. Discounts available on request

COVID-19 Impact Analysis

Like most other markets, the outbreak of COVID-19 had an unfavorable impact on the Animal Intestinal Health Market worldwide. This report discusses in detail the disruptions experienced by the market, the impact on flow of raw materials, manufacturing operations, production trends, consumer demand and the projected future of this market post pandemic.

The report has helped our clients:

• To describe and forecast the Animal Intestinal Health Market size, on the basis of various segmentations and geography, in terms of value and volume
• To measure the changing needs of customers/industries
• To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the market
• To gain competitive intelligence and uncover new opportunities
• To analyse opportunities in the market for stakeholders by identifying high-growth segments in Animal Intestinal Health Market
• To strategically profile key players and provide details of the current competitive landscape
• To analyse strategic approaches adopted by players in the market, such as product launches and developments, acquisitions, collaborations, contracts, expansions, and partnerships

Report Customization

Citius Research provides free customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Customize This Report

Frequently Asked Questions

The Global Animal Intestinal Health Market size was valued at $XX billion in 2023 and is anticipated to reach $XX billion by 2030 growing at a CAGR of XX%
The global Animal Intestinal Health Market is expected to grow at a CAGR of XX% from 2023 to 2030.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.
For further details request a free sample copy of this report here.

Table of Contents

Chapter 1. Introduction
  1.1. Market Scope
  1.2. Key Segmentations
  1.3. Research Objective
Chapter 2. Research Methodology & Assumptions
Chapter 3. Executive Summary
Chapter 4. Market Background
  4.1. Dynamics
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunity
    4.1.4. Challenges
  4.2. Key Trends in the Impacting the Market
    4.2.1. Demand & Supply
  4.3. Industry SWOT Analysis
  4.4. Porter’s Five Forces Analysis
  4.5. Value and Supply Chain Analysis
  4.6. Macro-Economic Factors
  4.7. COVID-19 Impact Analysis
    4.7.1. Global and Regional Assessment
  4.8. Profit Margin Analysis
  4.9. Trade Analysis
    4.9.1. Importing Countries
    4.9.2. Exporting Countries
  4.10. Market Entry Strategies
  4.11. Market Assessment (US$ Mn and Units)
Chapter 5. Global Animal Intestinal Health Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment A
  5.1. By Segment A, 2024 - 2030
    5.1.1. Sub-Segment A
    5.1.2. Sub-Segment B
  5.2. Opportunity Analysis
Chapter 6. Global Animal Intestinal Health Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment B
  6.1. By Segment B, 2024 - 2030
    6.1.1. Sub-Segment A
    6.1.2. Sub-Segment B
  6.2. Opportunity Analysis
Chapter 7. Global Animal Intestinal Health Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Segment C
  7.1. By Segment C, 2024 - 2030
    7.1.1. Sub-Segment A
    7.1.2. Sub-Segment B
  7.2. Opportunity Analysis
Chapter 8. Global Animal Intestinal Health Market Size (US$ Mn and Units), Forecast and Trend Analysis, By Region
  8.1. By Region, 2024 - 2030
    8.1.1. North America
    8.1.2. Latin America
    8.1.3. Europe
    8.1.4. MENA
    8.1.5. Asia Pacific
    8.1.6. Sub-Saharan Africa
    8.1.7. Australasia
  8.2. Opportunity Analysis
Chapter 9. North America Animal Intestinal Health Market Forecast and Trend Analysis
  9.1. Regional Overview
  9.2. Pricing Analysis
  9.3. Key Trends in the Region
    9.3.1. Supply and Demand
  9.4. Demographic Structure
  9.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    9.5.1. Sub-Segment A
    9.5.2. Sub-Segment B
  9.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    9.6.1. Sub-Segment A
    9.6.2. Sub-Segment B
  9.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    9.7.1. Sub-Segment A
    9.7.2. Sub-Segment B
  9.8. By Country, 2024 - 2030, (US$ Mn and Units)
    9.8.1. U.S.
    9.8.2. Canada
    9.8.3. Rest of North America
  9.9. Opportunity Analysis
Chapter 10. Latin America Animal Intestinal Health Market Forecast and Trend Analysis
  10.1. Regional Overview
  10.2. Pricing Analysis
  10.3. Key Trends in the Region
    10.3.1. Supply and Demand
  10.4. Demographic Structure
  10.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    10.5.1. Sub-Segment A
    10.5.2. Sub-Segment B
  10.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    10.6.1. Sub-Segment A
    10.6.2. Sub-Segment B
  10.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    10.7.1. Sub-Segment A
    10.7.2. Sub-Segment B
  10.8. By Country, 2024 - 2030, (US$ Mn and Units)
    10.8.1. Brazil
    10.8.2. Argentina
    10.8.3. Rest of Latin America
  10.9. Opportunity Analysis
Chapter 11. Europe Animal Intestinal Health Market Forecast and Trend Analysis
  11.1. Regional Overview
  11.2. Pricing Analysis
  11.3. Key Trends in the Region
    11.3.1. Supply and Demand
  11.4. Demographic Structure
  11.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    11.5.1. Sub-Segment A
    11.5.2. Sub-Segment B
  11.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    11.6.1. Sub-Segment A
    11.6.2. Sub-Segment B
  11.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    11.7.1. Sub-Segment A
    11.7.2. Sub-Segment B
  11.8. By Country, 2024 - 2030, (US$ Mn and Units)
    11.8.1. UK
    11.8.2. Germany
    11.8.3. France
    11.8.4. Spain
    11.8.5. Rest of Europe
  11.9. Opportunity Analysis
Chapter 12. MENA Animal Intestinal Health Market Forecast and Trend Analysis
  12.1. Regional Overview
  12.2. Pricing Analysis
  12.3. Key Trends in the Region
    12.3.1. Supply and Demand
  12.4. Demographic Structure
  12.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    12.5.1. Sub-Segment A
    12.5.2. Sub-Segment B
  12.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    12.6.1. Sub-Segment A
    12.6.2. Sub-Segment B
  12.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    12.7.1. Sub-Segment A
    12.7.2. Sub-Segment B
  12.8. By Country, 2024 - 2030, (US$ Mn and Units)
    12.8.1. Egypt
    12.8.2. Algeria
    12.8.3. GCC
    12.8.4. Rest of MENA
  12.9. Opportunity Analysis
Chapter 13. Asia Pacific Animal Intestinal Health Market Forecast and Trend Analysis
  13.1. Regional Overview
  13.2. Pricing Analysis
  13.3. Key Trends in the Region
    13.3.1. Supply and Demand
  13.4. Demographic Structure
  13.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    13.5.1. Sub-Segment A
    13.5.2. Sub-Segment B
  13.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    13.6.1. Sub-Segment A
    13.6.2. Sub-Segment B
  13.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    13.7.1. Sub-Segment A
    13.7.2. Sub-Segment B
  13.8. By Country, 2024 - 2030, (US$ Mn and Units)
    13.8.1. India
    13.8.2. China
    13.8.3. Japan
    13.8.4. ASEAN
    13.8.5. Rest of Asia Pacific
  13.9. Opportunity Analysis
Chapter 14. Sub-Saharan Africa Animal Intestinal Health Market Forecast and Trend Analysis
  14.1. Regional Overview
  14.2. Pricing Analysis
  14.3. Key Trends in the Region
    14.3.1. Supply and Demand
  14.4. Demographic Structure
  14.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    14.5.1. Sub-Segment A
    14.5.2. Sub-Segment B
  14.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    14.6.1. Sub-Segment A
    14.6.2. Sub-Segment B
  14.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    14.7.1. Sub-Segment A
    14.7.2. Sub-Segment B
  14.8. By Country, 2024 - 2030, (US$ Mn and Units)
    14.8.1. Ethiopia
    14.8.2. Nigeria
    14.8.3. Rest of Sub-Saharan Africa
  14.9. Opportunity Analysis
Chapter 15. Australasia Animal Intestinal Health Market Forecast and Trend Analysis
  15.1. Regional Overview
  15.2. Pricing Analysis
  15.3. Key Trends in the Region
    15.3.1. Supply and Demand
  15.4. Demographic Structure
  15.5. By Segment A , 2024 - 2030, (US$ Mn and Units)
    15.5.1. Sub-Segment A
    15.5.2. Sub-Segment B
  15.6. By Segment B, 2024 - 2030, (US$ Mn and Units)
    15.6.1. Sub-Segment A
    15.6.2. Sub-Segment B
  15.7. By Segment C, 2024 - 2030, (US$ Mn and Units)
    15.7.1. Sub-Segment A
    15.7.2. Sub-Segment B
  15.8. By Country, 2024 - 2030, (US$ Mn and Units)
    15.8.1. Australia
    15.8.2. New Zealand
    15.8.3. Rest of Australasia
  15.9. Opportunity Analysis
Chapter 16. Competition Analysis
  16.1. Competitive Benchmarking
    16.1.1. Top Player’s Market Share
    16.1.2. Price and Product Comparison
  16.2. Company Profiles
    16.2.1. Company A
      16.2.1.1. Company Overview
      16.2.1.2. Segmental Revenue
      16.2.1.3. Product Portfolio
      16.2.1.4. Key Developments
      16.2.1.5. Strategic Outlook
    16.2.2. Company B
      16.2.2.1. Company Overview
      16.2.2.2. Segmental Revenue
      16.2.2.3. Product Portfolio
      16.2.2.4. Key Developments
      16.2.2.5. Strategic Outlook
    16.2.3. Company C
      16.2.3.1. Company Overview
      16.2.3.2. Segmental Revenue
      16.2.3.3. Product Portfolio
      16.2.3.4. Key Developments
      16.2.3.5. Strategic Outlook
    16.2.4. Company D
      16.2.4.1. Company Overview
      16.2.4.2. Segmental Revenue
      16.2.4.3. Product Portfolio
      16.2.4.4. Key Developments
      16.2.4.5. Strategic Outlook
    16.2.5. Company E
      16.2.5.1. Company Overview
      16.2.5.2. Segmental Revenue
      16.2.5.3. Product Portfolio
      16.2.5.4. Key Developments
      16.2.5.5. Strategic Outlook
    16.2.6. Company F
      16.2.6.1. Company Overview
      16.2.6.2. Segmental Revenue
      16.2.6.3. Product Portfolio
      16.2.6.4. Key Developments
      16.2.6.5. Strategic Outlook
    16.2.7. Company G
      16.2.7.1. Company Overview
      16.2.7.2. Segmental Revenue
      16.2.7.3. Product Portfolio
      16.2.7.4. Key Developments
      16.2.7.5. Strategic Outlook
    16.2.8. Company H
      16.2.8.1. Company Overview
      16.2.8.2. Segmental Revenue
      16.2.8.3. Product Portfolio
      16.2.8.4. Key Developments
      16.2.8.5. Strategic Outlook
    16.2.9. Company I
      16.2.9.1. Company Overview
      16.2.9.2. Segmental Revenue
      16.2.9.3. Product Portfolio
      16.2.9.4. Key Developments
      16.2.9.5. Strategic Outlook
    16.2.10. Company J
      16.2.10.1. Company Overview
      16.2.10.2. Segmental Revenue
      16.2.10.3. Product Portfolio
      16.2.10.4. Key Developments
      16.2.10.5. Strategic Outlook
Chapter 17. Go-To-Market Strategy

Research Methodology

We follow a robust research methodology to analyze the market in order to provide our clients with qualitative and quantitative analysis which has a very low or negligible deviance. Extensive secondary research supported by primary data collection methods help us to thoroughly understand and gauge the market. We incorporate both top-down and bottom-up approach for estimating the market. The below mentioned methods are then adopted to triangulate and validate the market.

Secondary data collection and interpretation

Secondary research includes sources such as published books, articles in journals, news media and published businesses, government and international body publications, and associations. Sources also include paid databases such as Hoovers, Thomson Reuters, Passport and others. Data derived through secondary sources is further validated through primary sources. The secondary sources also include major manufacturers mapped on the basis of revenues, product portfolios, and sales channels.

Primary data collection

Primary data collection methods include conducting interviews with industry experts and various stakeholders across the supply chain, such as raw material suppliers, manufacturers, product distributors and customers. The interviews are either telephonic or face-to-face, or even a combination of both. Prevailing trends in the industry are gathered by conducting surveys. Primary interviews also help us to understand the market drivers, restraints and opportunities, along with the challenges in the market. This method helps us in validating the data gathered through secondary sources, further triangulating the data and developing it through our statistical tools. We generally conduct interviews with -

  • CEOs, Directors, and VPs
  • Sales and Marketing Managers
  • Plant Heads and Manufacturing Department Heads
  • Product Specialists

Supply Side and Demand Side Data Collection

Supply side analysis is based on the data collected from the manufacturers and the product providers in terms of their segmental revenues. Secondary sources for this type of analysis include company annual reports and publications, associations and organisations, government publications and others.

Demand side analysis is based upon the consumer insights who are the end users of the particular product in question. They could be an individual user or an organisation. Such data is gathered through consumer surveys and focused group interviews.

Market Engineering

As a primary step, in order to develop the market numbers we follow a vigorous methodology that includes studying the parent market of the niche product and understanding the industry trends, acceptance among customers of the product, challenges, future growth, and others, followed by further breaking down the market under consideration into various segments and sub-markets. Additionally, in order to cross-validate the market, we also determine the top players in the market, along with their segmental revenues for the said market. Our secondary sources help us to validate the market share of the top players. Using both the qualitative and quantitative analysis of all the possible factors helps us determine the market numbers which are inclined towards accuracy.

Request a detailed Research Methodology for the market.

Request Customization or Sample Report

To request a sample report or for any inquiry regarding this report, please fill out the form below

Yes, I have read the Privacy Policy.

Related Reports






latest reports